Can AI predict drug trial failures before they happen?
AI companies are running virtual clinical trials to predict drug success, cut costly failures and guide pharma R&D, as BioinvestGPT and QuantHealth show how simulations may improve outcomes for human studies
Reuters5 min read
Share

AI firms say simulations are being used to identify which pharmaceutical programs are worth moving forward and to assess the value of acquisition targets. As AI tools get better at flagging clinical risks, they say unexpected trial failures may become less frequent. (Illustration: Reuters)
Add Emirates 24|7 to your Google News
Text Size:
